Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novartis AG Receives European Approval For Meningitis B Vaccine-Reuters


Tuesday, 22 Jan 2013 02:02am EST 

Reuters reported that Novartis AG has clinched European approval for the first vaccine against meningitis B, and will seek to sell the drug as soon as possible. 

Company Quote

93.05
0.95 +1.03%
19 Dec 2014